Arrhythmia: Clinical Trials

25 trials for Arrhythmia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 2 terminated, 1 unknown, 1 withdrawn. 25 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 325Completed 21, Terminated 2, Unknown 1, Withdrawn 1
Phase 22Completed 1, Withdrawn 1

Follow Arrhythmia: new trials by email Literature Review of Arrhythmia trials Research Report on Arrhythmia

Trials (filtered) newest first · largest first

All 25 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intra Amniotic Injection of DIGOXIN for Feticide in Second Trimester Termination of Pregnancy
Intra-amniotic injection of DIGOXIN - Arrhythmia, ECG Changes
Phase 3UnknownMeir Medical Center1002013-11-012013-09-26
Effect of Colchicine on the Incidence of Atrial Fibrillation in Open Heart Surgery Patients
Colchicine - Arrhythmia
Phase 3CompletedJordan Collaborating Cardiology Group3602012-10-012018-01-23
THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation
THERMOCOOL® SMARTTOUCH™ Catheter - Heart Diseases, Arrhythmia
Phase 3CompletedBiosense Webster, Inc.1722011-06-012025-02-04
Empiric Quinidine for Asymptomatic Brugada Syndrome
quinidine, no therapy - Arrhythmia
Phase 2 / Phase 3WithdrawnInternational Registry of Asymptomatic Brugada Syndrome2009-12-012020-02-13
Mental Stress Reduction in Defibrillator Patients
Cognitive Behavioral Stress Management (CBSM), Patient Education - Cardiomyopathy, Dilated, Arrhythmia
Phase 3TerminatedUS Department of Veterans Affairs1292008-09-012014-12-22
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study
Radiofrequency Ablation - Heart Diseases, Arrhythmia
Phase 3TerminatedBiosense Webster, Inc.102008-09-012025-02-04
Effects of Docosahexaenoic Acid (DHA) on Heart Rate Variability in Elderly Patients
Docosahexaenoic acid (DHA), Placebo - Arrhythmia
Phase 2 / Phase 3CompletedCampus Bio-Medico University502008-06-012009-11-25
Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation
Olmesartan - Heart Disease, Arrhythmia
Phase 3CompletedAtrial Fibrillation Network4222005-01-012012-09-11
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter, Antiarrhythmic drug - Heart Diseases, Arrhythmia
Phase 3CompletedBiosense Webster, Inc.1672004-10-012017-10-24
SOFA: Study on Omega-3 Fatty Acids and Ventricular Arrhythmia
Supplementation with fish oil versus placebo - Arrhythmia
Phase 3CompletedWageningen Centre for Food Sciences5462001-10-012006-07-21
Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators
Azimilide Dihydrochloride, placebo - Arrhythmia
Phase 3CompletedForest Laboratories6332001-09-012011-10-03
Public Access Defibrillation (PAD) Community Trial
defibrillator - Arrhythmia, Heart Arrest
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1999-09-012016-04-14
Fatty Acid Antiarrhythmia Trial (FAAT)
dietary polyunsaturated fatty acid - Arrhythmia, Heart Diseases
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1999-03-012016-03-16
Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
amiodarone, defibrillators, implantable - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1997-05-012016-05-13
Mode Selection Trial in Sinus Node Dysfunction (MOST)
pacemaker, artificial - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedMt. Sinai Medical Center, Miami1995-06-012016-02-23
Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
amiodarone, sotalol, propafenone - Arrhythmia, Atrial Fibrillation
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1995-03-012016-03-25
Coronary Artery Bypass Graft (CABG) Patch Trial
defibrillators, implantable - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1992-12-012016-11-07
Antiarrhythmics Versus Implantable Defibrillators (AVID)
defibrillators, implantable, amiodarone amiodarone, sotalol - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1992-09-012016-04-14
Multicenter Unsustained Tachycardia Trial (MUSTT)
electrophysiology, anti-arrhythmia agents, defibrillators, implantable - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1991-09-012017-01-16
Digitalis Investigation Group (DIG)
digitalis - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1990-06-012016-07-12

Showing 20 of 25. Sign in to see all of them.

Narrower conditions

Arrhythmias, Cardiac (25)  ·  Heart Diseases (18)  ·  Cardiovascular Diseases (12)  ·  Death, Sudden, Cardiac (9)  ·  Atrial Fibrillation (7)  ·  Ventricular Fibrillation (7)  ·  Myocardial Infarction (5)  ·  Tachycardia, Ventricular (5)  ·  Coronary Disease (3)  ·  Heart Arrest (3)  ·  Myocardial Ischemia (3)  ·  Heart Failure (2)  ·  Stroke (2)  ·  Arrhythmia, Sinus (1)  ·  Brugada Syndrome (1)

Broader conditions

Pathologic Processes (25)  ·  Pathological Conditions, Signs and Symptoms (25)  ·  Cardiovascular Diseases (13)  ·  Death (9)  ·  Death, Sudden (9)  ·  Heart Arrest (8)  ·  Vascular Diseases (8)  ·  Cardiac Conduction System Disease (7)  ·  Heart Diseases (7)  ·  Infarction (5)  ·  Ischemia (5)  ·  Necrosis (5)  ·  Tachycardia (5)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)

Interventions

Amiodarone (4)  ·  Defibrillators, Implantable (4)  ·  Quinidine (4)  ·  Sotalol (4)  ·  Procainamide (3)  ·  Anti-Arrhythmia Agents (2)  ·  Imipramine (2)  ·  Mexiletine (2)  ·  Pacemaker, Artificial (2)  ·  Propafenone (2)  ·  Adrenergic beta-Antagonists (1)  ·  Ambulatory Care Facilities (1)  ·  Cardiopulmonary Resuscitation (1)  ·  Catheter Ablation (1)  ·  Colchicine (1)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (10)  ·  Biosense Webster, Inc. (3)  ·  Atrial Fibrillation Network (1)  ·  Campus Bio-Medico University (1)  ·  Forest Laboratories (1)  ·  International Registry of Asymptomatic Brugada Syndrome (1)  ·  Jordan Collaborating Cardiology Group (1)  ·  Massachusetts General Hospital (1)  ·  Meir Medical Center (1)  ·  Mt. Sinai Medical Center, Miami (1)  ·  US Department of Veterans Affairs (1)  ·  University of Utah (1)  ·  University of Washington (1)  ·  Wageningen Centre for Food Sciences (1)

Countries

Italy (4)  ·  United States (4)  ·  Germany (3)  ·  Netherlands (3)  ·  Belgium (2)  ·  Canada (2)  ·  Czechia (2)  ·  Israel (2)  ·  Poland (2)  ·  Austria (1)  ·  Brazil (1)  ·  France (1)  ·  Japan (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Kerry Lee (3)  ·  David Wilber, MD (2)  ·  H. Greene (2)  ·  Alfred Hallstrom (1)  ·  Allan Barker (1)  ·  Andrea Natale, MD (1)  ·  Andreas Goette, MD (1)  ·  Charles Laubach (1)  ·  David J Wilber, MD (1)  ·  David Richardson (1)  ·  Douglas L Packer, MD (1)  ·  Douglas Russell, MD PhD (1)  ·  E. Michau (1)  ·  Edgar Lichstein (1)

Results publications

PMID 16772624, PMID 18371559, PMID 19704100, PMID 19917887, PMID 20103757, PMID 20884379, PMID 20940250, PMID 22032709, PMID 22157519, PMID 23280225, PMID 23541974, PMID 24016511, PMID 24351885, PMID 24727258, PMID 25125294, PMID 26010524, PMID 27502857, PMID 27514751, PMID 28974568, PMID 29759747, PMID 31412732

NIH funding

R01HL031472 (1), R01HL033233 (1), R01HL034071 (1), R01HL062154 (1), U01HL045700 (1), U01HL048120 (1), U01HL048159 (1), U01HL049804 (1), U01HL055766 (1)